New heart valve device offers hope for patients too sick for surgery
NCT ID NCT06683729
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a new device called the HighLife TSMVR system for people with severe mitral regurgitation, a condition where the heart's mitral valve leaks. The device is placed through a catheter via a vein, avoiding open-heart surgery. The trial will include 240 participants who are not candidates for standard repair or surgery, and will track safety and effectiveness over 24 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcatheter mitral valve replacement device
What this could lead to
If successful, this could provide a new treatment option for people with severe mitral regurgitation who cannot have standard surgery or repair.
What could go wrong
This is an early study with 240 participants, and the device is new. Risks include complications from the procedure, device failure, or no benefit over existing options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL VALVE (MV) REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••